Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Key To Better Oncology Trials Could Be Better Historical Controls, Study Says

Executive Summary

The solution to poor clinical trial design in oncology trials could be better calculation of historical control rates used to create response measures, according to a study appearing in Clinical Cancer Research
Advertisement

Related Content

Targeted Oncologic Therapies Demand New Approach to Phase II/III Trials
Targeted Oncologic Therapies Demand New Approach to Phase II/III Trials
Advertisement
UsernamePublicRestriction

Register

PS048073

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel